DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- EBITDA, 2025
- −$466M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$466M | — |
| 2024 | −$342M | — |
| 2023 | −$240M | — |
| 2022 | −$169M | — |
| 2021 | −$149M | — |
| 2020 | −$58M | — |
| 2019 | −$14M | — |
Dyne Therapeutics, Inc.
$15.20−0.62 (−3.92%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$466M | — |
| 2024 | −$342M | — |
| 2023 | −$240M | — |
| 2022 | −$169M | — |
| 2021 | −$149M | — |
| 2020 | −$58M | — |
| 2019 | −$14M | — |